Long-term metformin use reduces gastric cancer risk in type 2 diabetics without insulin treatment: a nationwide cohort study.

MLA

Kim, Y. I., et al. “Long-Term Metformin Use Reduces Gastric Cancer Risk in Type 2 Diabetics without Insulin Treatment: A Nationwide Cohort Study.” Alimentary Pharmacology & Therapeutics, vol. 39, no. 8, Apr. 2014, pp. 854–63. EBSCOhost, https://doi.org/10.1111/apt.12660.

APA

Kim, Y.-I., Kim, S. Y., Cho, S.-J., Park, J.-H., Choi, I. J., Lee, Y. J., Lee, E. K., Kook, M.-C., Kim, C. G., Ryu, K. W., & Kim, Y.-W. (2014). Long-term metformin use reduces gastric cancer risk in type 2 diabetics without insulin treatment: a nationwide cohort study. Alimentary Pharmacology & Therapeutics, 39(8), 854–863. https://doi.org/10.1111/apt.12660

Chicago

Kim, Y-I, S Y Kim, S-J Cho, J-H Park, I J Choi, Y J Lee, E K Lee, et al. 2014. “Long-Term Metformin Use Reduces Gastric Cancer Risk in Type 2 Diabetics without Insulin Treatment: A Nationwide Cohort Study.” Alimentary Pharmacology & Therapeutics 39 (8): 854–63. doi:10.1111/apt.12660.